Table 2.
Parameters | Cases (n) | ALDOB-expression level
|
P-valuea | |
---|---|---|---|---|
Positive | Negative | |||
Sex | 0.537 | |||
Male | 82 | 29 | 53 | |
Female | 34 | 10 | 24 | |
Age (years) | 0.327 | |||
≥60 | 55 | 16 | 39 | |
<60 | 61 | 23 | 38 | |
Tumor size (mm) | 0.472 | |||
≥50 | 66 | 24 | 42 | |
<50 | 50 | 15 | 35 | |
Tumor location | 0.551 | |||
Fundus | 31 | 8 | 23 | |
Body | 40 | 15 | 25 | |
Antrum | 45 | 16 | 29 | |
Differentiation | 0.253 | |||
Well/moderate | 48 | 19 | 29 | |
Poor | 68 | 20 | 48 | |
Local invasion | 0.001* | |||
T1–T2 | 29 | 17 | 12 | |
T3–T4 | 87 | 22 | 65 | |
Node metastasis | <0.001* | |||
Yes | 86 | 19 | 67 | |
No | 30 | 20 | 10 | |
Distant metastasis | 0.014* | |||
Yes | 24 | 3 | 21 | |
No | 92 | 36 | 56 | |
TNM stage | ||||
I–II | 39 | 29 | 10 | <0.001* |
III–IV | 77 | 10 | 67 |
Notes:
Based on χ2 test;
significant difference.
Abbreviation: TNM, tumor-node-metastasis.